期刊文献+

局部抗青光眼药物治疗导致眼表毒性反应误诊临床分析 被引量:10

Clinical analysis of toxic effects on ocular surface induced by antiglaucoma eye drops
下载PDF
导出
摘要 目的:分析局部抗青光眼药物对眼表的毒性作用。方法:回顾性分析12例青光眼患者局部抗青光眼药物治疗诱导的局部不良反应。结果:12例青光眼患者均使用2种以上局部抗青光眼药物≥0.5a,出现眼部刺激症状,眼球充血、角膜点状染色,给予至少1种抗生素、1种抗病毒眼药水,和抗过敏眼药点眼,病情加重。停用所有眼局部用药后,眼部表现缓解、消失。结论:长期抗青光眼治疗,出现眼表疾病,或眼表疾病控制不满意、加重时均应考虑药物毒性的发生;局部抗青光眼药物导致的结膜和角膜改变是可逆的。 AIM: To evaluate the toxic effects of antiglaucoma eye drops on ocular surface. METHODS: The adverse effects on ocular induced by antiglaucoma eye drops were retrospectively analyzed. RESULTS: Twelve cases were treated with 2 or more antiglaucoma drugs for at least half a year, presented eye irritation symptoms, conjunctival redness and superficial punctuate keratitis. The eye symptoms and objective signs of conjunctival and corneal damages aggravated after treated with antibiotic, virus and anti-anaphylaxis drops, but after stopped all eye drops, those presentations mentioned above relieved or disappeared. CONCLUSION : Drug toxicity should be considered after long term use of antiglaucoma drops. The adverse effects on ocular induced by antiglaucoma eye drops are reversible.
作者 卢艳
出处 《国际眼科杂志》 CAS 2008年第12期2549-2550,共2页 International Eye Science
关键词 青光眼 局部药物治疗 药物不良反应 glaucoma antiglaucoma drop drug toxicity
  • 相关文献

参考文献2

二级参考文献33

  • 1王东,王霞.抗青光眼药物合用时对肾脏的损害[J].中国药物与临床,2004,4(4):298-300. 被引量:1
  • 2Y.H.ZOU,G.C.Y.Chiou.青光眼药物治疗的进展(英文)[J].国际眼科杂志,2005,5(3):411-422. 被引量:9
  • 3Broadway DC, Grierson I, O' Brien C, Hitchings RA. Adverse effects of topical antiglaucomatous medications, II : the outcome of filtration surgery [ J]. Arch Ophthalmol 1994 ; 112 : 1446-1454.
  • 4Eleftheriadis H, Cheong M, Sandeman S. Corneal toxicity secondary to inadvertent use of benzalkontum chloride preserved viscoelastic material in cataract surgery[ J ]. Br J Oph thalmol 2002 ; 86 : 299-305.
  • 5Miyake K, Ibaraki N,Goto Y. ESCRS Binkhorst lecture 2002: pseudophakic preservative maculopathy [ J ]. J Cataract Refract Surg 2003 ;29 : 1800-1810.
  • 6Herbst RA, Uter W,Pirker C,Findlay C. Allergic and nonallergic periorbital dermatitis:patch test results of the information network of the departments of dermatology during a 5-year period [ J ]. CODEDG (Contact Dermatitis )2004;51:13-19.
  • 7Pisella PJ, Pouliquen P, Baudouin C. Prevalence of octtlar symptoms and signs with preserved and preservative free glaucoma medication [ J ]. Br J Oph t halmol 2002;86:418.
  • 8Guenoun JM,Baudottin C,Rat P,Pauly A,Warnet JM,Brignole BF. In vitro study of inflammatory potential and toxicity profile of latanoprost, travoprost, and bimatoprost in conjunctiva-derived epithelial cells[ J]. Invest Ophthalmol Vis Sci 2005 ;46(7) :2444-2450.
  • 9Catherine PH,Debbasch B,Warnet JM,Baudouin C, Brignole F. In vitro effects of preservedand tmpreserved antiglaucoma drugson apoptotic marker expression by httman trabecttlar cells [ J]. Graefe Arch Clin Exp Ophthalmol 2003 ;241 : 1037-1043.
  • 10Lee DA, Higginbotham EJ. glaucoma and its treatment[ J]. Am J Health Syst Pharrn 2005 ;62 (7) :691-699.

共引文献29

同被引文献104

引证文献10

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部